ŠKODA, Jan and Renata VESELSKÁ. Cancer stem cells in sarcomas: Getting to the stemness core. Biochimica et Biophysica Acta - General Subjects. Amsterdam: Elsevier B.V., 2018, vol. 1862, No 10, p. 2134-2139. ISSN 0304-4165. Available from: https://dx.doi.org/10.1016/j.bbagen.2018.07.006.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Cancer stem cells in sarcomas: Getting to the stemness core.
Authors ŠKODA, Jan (203 Czech Republic, belonging to the institution) and Renata VESELSKÁ (203 Czech Republic, guarantor, belonging to the institution).
Edition Biochimica et Biophysica Acta - General Subjects, Amsterdam, Elsevier B.V. 2018, 0304-4165.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30204 Oncology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 3.681
RIV identification code RIV/00216224:14310/18:00106220
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1016/j.bbagen.2018.07.006
UT WoS 000443665300003
Keywords in English Cancer stem cells; sarcoma; markers; Sox2; pluripotency factors; mesenchymal stem cells
Tags International impact, Reviewed
Changed by Changed by: prof. RNDr. Renata Veselská, Ph.D., M.Sc., učo 1260. Changed: 15/2/2019 16:40.
Abstract
Sarcomas are rare tumors but represent the third most common malignancy in children. The cancer stem cell (CSC) paradigm is well established, and CSCs have been intensively studied in sarcomas in the past decade. This review summarizes current knowledge on CSCs in sarcomas and provides new perspectives on the role of a deregulated stemness program in sarcomagenesis. Cell surface markers have so far failed to specifically target sarcoma CSCs. Sarcomas likely arise from immature cells that undergo pathological reprogramming. Transcription factor Sox2, which is frequently upregulated in sarcomas, is directly involved in this process, and its crucial role in the acquisition and maintenance of the CSC phenotype has been demonstrated in various sarcomas. Sox2 is a core functional regulator of the stem-like state and is an outstanding marker of sarcoma CSCs. Fluorescence protein-based reporters of Sox2 expression might provide useful tools for subsequent studies of sarcoma CSCs.
Links
MUNI/A/0824/2017, interní kód MUName: Podpora výzkumné činnosti studentů molekulární biologie a genetiky 6 (Acronym: MolBiolGen)
Investor: Masaryk University, Category A
PrintDisplayed: 6/10/2024 11:46